​

Trevi Therapeutics Ownership | Who Owns Trevi Therapeutics?

OverviewForecastFinancialsChartTranscripts

Trevi Therapeutics Ownership Summary

Trevi Therapeutics is owned by 102.93% institutional investors, 0.63% insiders. Nea management company is the largest institutional shareholder, holding 9.08% of TRVI shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 2.85% of its assets in Trevi Therapeutics shares.

TRVI Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTrevi Therapeutics102.93%0.63%-3.56%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nea management company13.22M9.08%$246.59M
Fmr12.56M8.63%$234.30M
Blackrock funding, inc. /de11.16M7.66%$208.04M
Frazier life sciences management9.94M6.83%$185.37M
Vanguard group6.43M4.43%$80.56M
Wellington management group llp5.68M3.90%$106.02M
Vanguard capital management5.53M3.80%$103.15M
Vivo capital5.09M3.50%$95.02M
Blackrock3.14M3.15%$9.34M
Woodline partners lp4.08M2.80%$76.12M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nea management company13.22M15.53%$246.59M
Acorn capital advisors2.14M10.92%$40.00M
Pivotal bioventure partners investment advisor1.74M10.56%$32.50M
Vivo capital5.09M8.68%$95.02M
Artia global partners lp2.21M7.61%$41.23M
Superstring capital management lp524.22K6.17%$9.78M
Frazier life sciences management9.94M4.04%$185.37M
Bioimpact capital3.07M3.50%$57.32M
Saturn v capital management1.05M2.81%$19.62M
First light asset management2.10M2.38%$39.11M

Top Buyers

HolderShares% AssetsChange
Fmr12.56M0.01%4.52M
Woodline partners lp4.08M0.24%3.08M
First light asset management2.10M2.38%2.10M
Assenagon asset management1.53M0.04%1.53M
Barclays1.14M0.00%1.09M

Top Sellers

HolderShares% AssetsChange
Armistice capital---2.99M
Viking global investors lp1.54M0.08%-1.65M
Marshall wace, llp2.67M0.04%-1.29M
Rubric capital management lp2.50M0.43%-1.21M
Citadel advisors---1.20M

New Positions

HolderShares% AssetsChangeValue
First light asset management2.10M2.38%2.10M$39.11M
Assenagon asset management1.53M0.04%1.53M$28.45M
Saturn v capital management1.05M2.81%1.05M$19.62M
Sixth street partners management company965.40K0.00%965.40K$18.00M
Rock springs capital management lp260.00K0.24%260.00K$4.85M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Twin peaks wealth advisors-29.00
Clearstead advisors-39.00
Coldstream capital management-78.00
Capital performance advisors llp-134.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20262228.29%149,859,43311.06%1021.20%13324.30%59-4.84%
Mar 31, 202680-58.12%18,222,593-86.02%120.16%44-58.49%23-54.00%
Dec 31, 2025113-34.30%64,895,069-49.82%440.45%68-32.67%27-37.21%
Sep 30, 20251699.03%127,167,79618.08%971.43%99-1.98%4334.38%
Jun 30, 202516214.08%114,632,70430.70%871.58%1046.12%336.45%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest4.07M2.85%17.83K
Vanguard Morn Total Stk Mkt Idx Investor4.05M2.85%20.23K
Vanguard Total Stock Mkt Idx Inv4.05M2.85%20.23K
iShares Russell 2000 ETF2.70M1.91%-48.00K
Eventide Healthcare & Life Sciences I2.62M1.85%-
Vanguard US Total Market Shares ETF1.78M1.84%-
Fidelity Select Biotechnology2.37M1.67%-
Fidelity Small Cap Growth1.95M1.37%-
Fidelity Growth Compy Commingled Pl S1.38M0.97%-
Vanguard Institutional Extnd Mkt Idx Tr1.36M0.95%2.33K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 25, 2025SCIASCIA THOMAS Chief Scientific OfficerSell$17.36K
Mar 21, 2025GOOD JENNIFER L President & CEOSell$34.62K
Mar 10, 2025Simon Farrell Chief Commercial OfficerSell$31.10K
Mar 10, 2025Simon Farrell Chief Commercial OfficerSell$517.78K
Sep 06, 2024GOOD JENNIFER L President & CEOSell$12.78K

Insider Transactions Trends

DateBuySell
2026 Q2--
2026 Q1--
2025 Q4--
2025 Q2--
2025 Q1-4

TRVI Ownership FAQ

Who Owns Trevi Therapeutics?

Trevi Therapeutics shareholders are primarily institutional investors at 102.93%, followed by 0.63% insiders and -3.56% retail investors. The average institutional ownership in Trevi Therapeutics's industry, Biotech Stocks , is 379.61%, which Trevi Therapeutics falls below.

Who owns the most shares of Trevi Therapeutics?

Trevi Therapeutics’s largest shareholders are Nea management company (13.22M shares, 9.08%), Fmr (12.56M shares, 8.63%), and Blackrock funding, inc. /de (11.16M shares, 7.66%). Together, they hold 25.37% of Trevi Therapeutics’s total shares outstanding.

Does Blackrock own Trevi Therapeutics?

Yes, BlackRock owns 3.15% of Trevi Therapeutics, totaling 3.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 9.34M$. In the last quarter, BlackRock increased its holdings by 759.41K shares, a 31.97% change.

Who is Trevi Therapeutics’s biggest shareholder by percentage of total assets invested?

Nea management company is Trevi Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.53% of its assets in 13.22M Trevi Therapeutics shares, valued at 246.59M$.

Who is the top mutual fund holder of Trevi Therapeutics shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Trevi Therapeutics shares, with 2.85% of its total shares outstanding invested in 4.07M Trevi Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools